Cart
sales@molnova.com
Home -
Products -
Membrane Transporter/Ion Channel -
TRP/TRPV Channel -
Vanilloid receptor antagonist 1
Vanilloid receptor antagonist 1
CAS No. 871814-52-7
Vanilloid receptor antagonist 1( 4-(7-Hydroxy-2-isopropyl-4-oxoquinazolin-3(4H)-yl)benzonitrile )
Catalog No. M24886 CAS No. 871814-52-7
Vanilloid receptor antagonist 1 is a potent vanilloid receptor TRPV1 antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 5MG | 235 | In Stock |
|
| 10MG | 353 | In Stock |
|
| 25MG | 601 | In Stock |
|
| 50MG | 830 | In Stock |
|
| 100MG | 1181 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVanilloid receptor antagonist 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionVanilloid receptor antagonist 1 is a potent vanilloid receptor TRPV1 antagonist.
-
DescriptionVanilloid receptor antagonist 1 is a potent vanilloid receptor TRPV1 antagonist.
-
In Vitro——
-
In Vivo——
-
Synonyms4-(7-Hydroxy-2-isopropyl-4-oxoquinazolin-3(4H)-yl)benzonitrile
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRPV1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number871814-52-7
-
Formula Weight305.33
-
Molecular FormulaC18H15N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (327.51 mM)
-
SMILESCC(C)C(N1c(cc2)ccc2C#N)=Nc(cc(cc2)O)c2C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ritchie T J , Culshaw A J , Brain C T , et al. Quinazolinone derivatives useful as vanilloid antagonists: US, US8349852 B2[P]. 2012.
molnova catalog
related products
-
Vitexin
Vitexin protects brain against cerebral I/R injury, and this effect may be regulated by mitogen-activated protein kinase (MAPK) and apoptosis signaling pathways.
-
BI-749327
BI-749327 is a high selectivity and orally bioavailable antagonist of TRPC6 (IC50s: 13 nM, 19 nM and 15 nM for mouse, human and guinea pig TRPC6).
-
GSK1702934A
GSK1702934A, a selective TRPC3 agonist, modulates cardiac contractility and arrhythmogenesis through TRPC3 activation.
